Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies - PubMed (original) (raw)

. 1998 Apr;152(4):879-84.

Affiliations

Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies

M Baba et al. Am J Pathol. 1998 Apr.

Abstract

Lewy bodies (LBs) are hallmark lesions of degenerating neurons in the brains of patients with Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Recently, a point mutation in the gene encoding the presynaptic alpha-synuclein protein was identified in some autosomal-dominantly inherited familial PD pedigrees, and light microscopic studies demonstrated alpha-synuclein immunoreactivity in LBs of sporadic PD and DLB. To characterize alpha-synuclein in LBs, we raised monoclonal antibodies (MAbs) to LBs purified from DLB brains and obtained a MAb specific for alpha-synuclein that intensely labeled LBs. Light and electron microscopic immunocytochemical studies performed with this MAb as well as other antibodies to alpha-and beta-synuclein showed that alpha-synuclein, but not beta-synuclein, is a component of LBs in sporadic PD and DLB. Western blot analyses of highly purified LBs from DLB brains showed that full-length as well as partially truncated and insoluble aggregates of alpha-synuclein are deposited in LBs. Thus, these data strongly implicate alpha-synuclein in the formation of LBs and the selective degeneration of neurons in sporadic PD and DLB.

PubMed Disclaimer

References

    1. Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9141-5 - PubMed
    1. J Neuropathol Exp Neurol. 1996 Mar;55(3):259-72 - PubMed
    1. Am J Pathol. 1996 May;148(5):1517-29 - PubMed
    1. Biochemistry. 1996 Oct 29;35(43):13709-15 - PubMed
    1. Neurology. 1996 Nov;47(5):1113-24 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources